MedPath

K Lung cancer Screening pilot trial (UKLS)

Not Applicable
Completed
Conditions
ung cancer
Cancer
Malignant neoplasm of bronchus and lung
Registration Number
ISRCTN78513845
Lead Sponsor
Royal Liverpool & Broadgreen University Hospital Trust (UK)
Brief Summary

2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26173719 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26645413 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27224642 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27471048 results 2017 Results article in http://www.ncbi.nlm.nih.gov/pubmed/28710339 results 2021 Results article in https://doi.org/10.1016/j.lanepe.2021.100179 (added 30/09/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
4055
Inclusion Criteria

1. Risk criteria based on the LLP Risk Prediction Model (includes age, sex, smoking duration, history of previous pneumonia, history of previous cancer, family history [early/late onset], exposure to asbestos - algorithm)
2. Males and females aged between 50 to 75 years old
3. Fully informed written consent given

Exclusion Criteria

1. Unable to give consent
2. Co-morbidity which would unequivocally contraindicate either screening or treatment if lung cancer were detected
3. A CT scan of the chest performed within one year of the invitation to be screened
4. Any condition precluding written informed consent
5. Inability to lie flat
6. Weight greater than 200 kg (too large for CT scanner)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath